MAGNOLIA NEUROSCIENCES

magnolia-neurosciences-logo

Magnolia Neurosciences aims to discover and develop proprietary, selective, and drug-like small molecule therapeutics for the prevention of neuronal cell death, thereby providing novel treatment options for patients suffering from neurodegeneration and related conditions. Magnolia Neurosciences Corporation, created to pursue technologies developed at The University of Texas MD Anderson Cancer Center’s Therapeutics Discovery Division and the Neurodegeneration Consortium (NDC), is a New York-based Accelerator Life Science Partner portfolio company.

#People #Financial #Website #More

MAGNOLIA NEUROSCIENCES

Industry:
Biotechnology Health Care Neuroscience Wellness

Founded:
2018-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.magnolianeurosciences.com

Total Employee:
1+

Status:
Active

Contact:
646-828-5990

Total Funding:
49.39 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF WordPress Apache Wordpress Plugins Euro Microsoft Exchange Online Office 365 Mail Google Maps


Current Employees Featured

philip-jones_image

Philip Jones
Philip Jones Founder @ Magnolia NeuroSciences
Founder

thong-ngo_image

Thong Ngo
Thong Ngo Chief Executive Officer, President and Board Member @ Magnolia NeuroSciences
Chief Executive Officer, President and Board Member

Founder


philip-jones_image

Philip Jones

Investors List

md-anderson-cancer-center-19d6_image

MD Anderson Cancer Center

MD Anderson Cancer Center investment in Series A - Magnolia NeuroSciences

180-degree-capital_image

180 Degree Capital

180 Degree Capital investment in Series A - Magnolia NeuroSciences

watson-fund_image

Watson Fund

Watson Fund investment in Series A - Magnolia NeuroSciences

accelerator-life-science-partners_image

Accelerator Life Science Partners

Accelerator Life Science Partners investment in Series A - Magnolia NeuroSciences

pfizer-venture-investments_image

Pfizer Venture Investments

Pfizer Venture Investments investment in Series A - Magnolia NeuroSciences

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Series A - Magnolia NeuroSciences

wuxi-apptec_image

WuXi AppTec

WuXi AppTec investment in Series A - Magnolia NeuroSciences

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series A - Magnolia NeuroSciences

johnson-johnson-innovation_image

Johnson & Johnson Innovation

Johnson & Johnson Innovation investment in Series A - Magnolia NeuroSciences

abbvie-biotech-ventures_image

AbbVie Biotech Ventures

AbbVie Biotech Ventures investment in Series A - Magnolia NeuroSciences

Official Site Inspections

http://www.magnolianeurosciences.com Semrush global rank: 6.03 M Semrush visits lastest month: 1.35 K

  • Host name: gra.graphicainc.com
  • IP address: 162.241.142.33
  • Location: Provo United States
  • Latitude: 40.2342
  • Longitude: -111.6442
  • Metro Code: 770
  • Timezone: America/Denver
  • Postal: 84606

Loading ...

More informations about "Magnolia NeuroSciences"

Magnolia NeuroSciences - Crunchbase Company Profile & Funding

Contact Email info@magnolianeurosciences.com Phone Number 646-828-5990 Magnolia Neurosciences aims to discover and develop proprietary, selective, and drug-like small …See details»

Magnolia Neuroscience - VentureRadar

Similar Companies: Genentech USA Publicly Traded Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people …See details»

Magnolia NeuroSciences - Craft

Magnolia NeuroSciences has 5 employees across 2 locations and $31 m in total funding,. See insights on Magnolia NeuroSciences including office locations, competitors, revenue, …See details»

Magnolia Neurosciences Overview | SignalHire Company Profile

Organization Website: magnolianeurosciences.com : Magnolia Neurosciences industries Biotech, Biotechnology, Life Sciences: Headquarters Location: 430 E 29th St, New York, 10016 US …See details»

Magnolia Neurosciences - PitchBook

Magnolia Neurosciences General Information Description. Developer of novel therapeutics designed to treat neurodegeneration and neuronal injuries. The company's proprietary …See details»

Magnolia Neurosciences Corporation - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Magnolia Neurosciences Corporation of New York, NY. Get the latest business insights from Dun & …See details»

Magnolia Neurosciences - Products, Competitors, Financials, …

Headquarters Location. 430 E 29th Street Suite 840. New York, New York, 10016, United States. 646-828-5990See details»

Magnolia Neurosciences Corporation Company Profile | New York, …

Address: 430 E 29TH St Ste 840 New York, NY, 10016-8367 United StatesSee details»

Overview, News & Similar companies - ZoomInfo.com

View Magnolia NeuroSciences (www.magnolianeurosciences.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as …See details»

Magnolia Neurosciences Corp.: Drug pipelines, Patents, Clinical …

Explore Magnolia Neurosciences Corp. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»

Magnolia Neurosciences - Company Profile & Staff Directory

Magnolia Neurosciences Corporation is a drug discovery and development company focused on the creation of a novel class of neuroprotective medicines. The company was launched by a …See details»

Magnolia Neurosciences Corp. - Drug pipelines, Patents ... - Patsnap

Www.magnolianeurosciences.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. …See details»

Magnolia NeuroSciences | Company | Mindmaps

Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.See details»

Magnolia Neurosciences Company Information - Funding, …

Track over 23,965 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 23,965 companies to help you find the right ones to partner with.See details»

Magnolia Neuroscience - VentureRadar

Website: http://magnolianeurosciences.com/ Develops medicines protecting the nervous system from damage in Alzheimer's, Parkinson's, traumatic brain injury, and ...See details»

Magnolia Neurosciences Corporation | CipherBio

Explore Magnolia Neurosciences Corporation's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

Magnolia Neurosciences Corporation in New York, NY - (206) 957 …

Magnolia Neurosciences Corporation is in the Medical Research, Commercial business. View competitors, revenue, employees, website and phone number.See details»

Magnolia Neurosciences Corporation - CAGE.report

DUNS registration and contact information for . Location, website, and products offered. Doing business asSee details»

Magnolia Neurosciences (H6KRE9LT6M24) - highergov.com

Eurodegenerative diseases and neuronal injuries continue to be an area rife with substantial unmet medical need. Targeting the underlying mechanisms of these diseases is an area of …See details»

Magnolia Neurosciences - CB Insights

Margarita has lead investments in over a dozen biotech companies in the US and Europe. She is responsible for AbbVie Ventures’ investments in Alector (NASDAQ: ALEC), Morphic …See details»

linkstock.net © 2022. All rights reserved